Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Compare daily and long-term volatility across major coins to inform allocation and risk controls in your portfolio.
20,930 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
A major investment firm just snapped up a sizable stake in Integer Holdings as its shares slide. Learn what this coul...
A dramatic surge in a single year can turn heads, but investors need more than headlines. This article dives into whe...
CoreCivic has faced a share-price headwind even as revenue climbs. A notable $5 million stake by Hahn Capital signals...
A high-profile stance can carry a price in Hollywood. This article explains the financial lessons from Susan Sarandon...
A weekend missile strike challenges Dubai’s safe-haven status, triggering fresh volatility in energy, equities, and t...
Markets are starting to price in escalation as Iran tensions rise, with oil and Treasuries moving and loan pricing ed...
Tech stocks lead an early market rebound as progress in Middle East talks eases risk concerns. The Nasdaq Composite m...
ExxonMobil stock near $150 highlights a broader earnings and cash-flow story that many retail investors overlook. Her...
DTI's 2025 earnings narrative sheds light on demand for drilling tools and oilfield equipment. This guide breaks down...
The Middle East crisis is sending shockwaves through the stock market, but airlines are taking the biggest hit. This ...
Investors are tracing a familiar 1990 Gulf War playbook as oil climbs and energy shares outperform, while the broader...